Oppenheimer & CO Inc Novavax Inc Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Novavax Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 12,014 shares of NVAX stock, worth $96,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,014

Previous 11,644 3.18%

Holding current value

$96,832

Previous $147,000 2.72%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$10.71 - $17.11 $3,962 - $6,330	370 Added 3.18%	12,014 $151,000
Q2 2024 Aug 07, 2024	SELL	$3.89 - $20.97 $1,847 - $9,960	-475 Reduced 3.92%	11,644 $147,000
Q1 2024 May 06, 2024	SELL	$3.76 - $6.02 $9,663 - $15,471	-2,570 Reduced 17.5%	12,119 $57,000
Q4 2023 Feb 13, 2024	SELL	$4.8 - $7.67 $8,054 - $12,870	-1,678 Reduced 10.25%	14,689 $70,000
Q3 2023 Nov 07, 2023	SELL	$6.81 - $9.74 $18,727 - $26,785	-2,750 Reduced 14.39%	16,367 $118,000
Q2 2023 Aug 02, 2023	SELL	$6.67 - $9.52 $30,348 - $43,316	-4,550 Reduced 19.23%	19,117 $142,000
Q1 2023 May 10, 2023	SELL	$5.76 - $12.48 $3,456 - $7,488	-600 Reduced 2.47%	23,667 $164,000
Q4 2022 Feb 07, 2023	SELL	$8.86 - $25.04 $86,128 - $243,413	-9,721 Reduced 28.6%	24,267 $249,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $376,084 - $1.57 Million	-20,664 Reduced 37.81%	33,988 $619,000
Q2 2022 Aug 08, 2022	SELL	$36.28 - $75.29 $179,586 - $372,685	-4,950 Reduced 8.31%	54,652 $2.81 Million
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $1.08 Million - $2.21 Million	15,452 Added 35.0%	59,602 $4.39 Million
Q4 2021 Feb 02, 2022	BUY	$134.56 - $217.97 $1.91 Million - $3.09 Million	14,197 Added 47.4%	44,150 $6.32 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $4.43 Million - $6.74 Million	24,892 Added 491.84%	29,953 $6.21 Million
Q2 2021 Aug 03, 2021	SELL	$121.0 - $257.67 $80,586 - $171,608	-666 Reduced 11.63%	5,061 $1.08 Million
Q1 2021 May 10, 2021	BUY	$112.98 - $319.93 $195,455 - $553,478	1,730 Added 43.28%	5,727 $1.04 Million
Q4 2020 Feb 11, 2021	BUY	$78.74 - $139.5 $10,787 - $19,111	137 Added 3.55%	3,997 $446,000
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $322,288 - $724,215	-4,057 Reduced 51.24%	3,860 $418,000
Q2 2020 Aug 11, 2020	SELL	$13.86 - $83.61 $280,886 - $1.69 Million	-20,266 Reduced 71.91%	7,917 $660,000
Q1 2020 May 08, 2020	BUY	$3.93 - $16.0 $110,759 - $450,928	28,183 New	28,183 $382,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Novavax Inc Transaction History